Pharmacokinetic and Pharmacodynamic Study of Glufast Tablets 10mg(Mitiglinide)

Clinical trial NCT04349696 · COMPLETED

Trial details

NCT number: NCT04349696
Sponsor: Orient Europharma Co., Ltd.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus Liver Dysfunction

Start date: 2014-02-11
Primary completion: 2018-04-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.